RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tayo Adekiya to Drug Carriers

Back to Details
This is a "connection" page, showing publications Tayo Adekiya has written about Drug Carriers.
Tayo Adekiya
Connection Strength
0.412
Drug Carriers
  1. Adekiya TA, Owoseni O. Emerging frontiers in nanomedicine targeted therapy for prostate cancer. Cancer Treat Res Commun. 2023; 37:100778.
    View in: PubMed
    Score: 0.215
  2. Adekiya TA, Kumar P, Kondiah PPD, Ubanako P, Choonara YE. In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against S. mansoni Infection in Preclinical Murine Models. Int J Mol Sci. 2022 Aug 22; 23(16).
    View in: PubMed
    Score: 0.197
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support